Valuation: Merck KGaA

Market Cap 65.09B 71.64B 60.14B 54.32B 103B 6,727B 106B 723B 287B 3,610B 269B 263B 11,435B P/E 2026 *
25.1x
P/E 2027 * 21.3x
Enterprise Value 72.61B 79.92B 67.09B 60.6B 114B 7,504B 118B 807B 320B 4,027B 300B 294B 12,756B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 3.1x
Free-Float
29.73%
Yield 2026 *
1.57%
Yield 2027 * 1.61%
1 day+0.07%
1 week+0.64%
Current month-1.06%
1 month+4.50%
3 months+9.83%
6 months+27.57%
Current year+22.10%
1 week 144
Extreme 144
156.25
1 month 141.6
Extreme 141.6
156.25
Current year 100.7
Extreme 100.7
156.25
1 year 100.7
Extreme 100.7
156.25
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 61 01/05/2026
Director of Finance/CFO 56 01/07/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 26/04/2019
Director/Board Member 60 09/05/2014
Director/Board Member 50 28/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
25/03/26 Buy

Chief Executive Officer

3,386 0.0026%
25/03/26 Buy

Chief Financial Officer

4,563 0.0035%
27/03/25 Buy 1,401 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%+0.64%+27.35%-3.51% 71.78B
-0.82%+5.74%+39.64%+143.26% 1,286B
-1.12%+2.29%+44.21%+89.89% 688B
-0.16%+1.11%+26.76%+114.06% 521B
+1.14%+4.87%+43.06%+71.97% 386B
-2.23%-1.55%+55.47%+42.54% 364B
+1.27%+2.01%+30.01%+62.35% 302B
+0.37%+0.75%+3.71%+39.09% 287B
-0.72%+0.41%+37.29%+69.33% 252B
-0.30%+0.41%+34.04%+123.32% 208B
Average -0.25%+1.93%+34.15%+75.23% 437B
Weighted average by Cap. -0.46%+3.21%+36.81%+96.59%

Financials

2026 *2027 *
Net sales 21.6B 23.77B 19.95B 18.02B 34.02B 2,232B 35.21B 240B 95.08B 1,198B 89.2B 87.32B 3,794B 22.82B 25.12B 21.08B 19.04B 35.94B 2,358B 37.2B 254B 100B 1,266B 94.25B 92.25B 4,009B
Net income 2.49B 2.74B 2.3B 2.08B 3.92B 257B 4.06B 27.65B 10.96B 138B 10.28B 10.06B 437B 2.99B 3.29B 2.76B 2.49B 4.7B 309B 4.87B 33.19B 13.15B 166B 12.34B 12.08B 525B
Net Debt 7.52B 8.28B 6.95B 6.28B 11.85B 778B 12.27B 83.6B 33.12B 417B 31.08B 30.42B 1,322B 5.62B 6.18B 5.19B 4.69B 8.85B 580B 9.16B 62.4B 24.73B 311B 23.2B 22.71B 987B
Projected Income Statement - Annual - Merck KGaA
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
61,949
Date Price Change Volume
16/11/26 €149.70 +0.07% 258,209
13/11/26 €149.60 +0.98% 283,625
12/11/26 €148.15 -2.28% 479,387
11/11/26 €151.60 +1.51% 216,372
10/11/26 €149.35 +0.10% 277,215
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Merck KGaA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
149.70EUR
Average target price
156.86EUR
Spread / Average Target
+4.78%